FDA import alert status
Jiangsu Longliqi Bioscience Co Ltd.
China · appears on 2 FDA import alerts
2
Red-list alerts
0
Green-list alerts
China
Country
10/13/2022
Last entry seen
What this means
As published on the official FDA import alert list, this firm appears on 2 red lists. A red-list firm is subject to Detention Without Physical Examination (DWPE): FDA can detain its shipments at the border automatically, without sampling. The burden shifts to the importer to prove the goods are not violative.
Import alert status changes over time. Import Alert Radar re-checks the official FDA source every day; the entries below reflect the latest refresh (2026-07-21 UTC).
Do you buy from Jiangsu Longliqi Bioscience Co Ltd.?
Put this supplier on watch: we re-check the official FDA import alert list daily and email you the day Jiangsu Longliqi Bioscience Co Ltd. is added to a red list — or removed from one — so a detained shipment never catches you by surprise.
Red-list entries
- Import Alert 66-41RED · 07/30/2010
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Import Alert 66-79RED · 10/13/2022
Detention Without Physical Examination of Drugs From Foreign Establishments Refusing FDA Inspection
Is Jiangsu Longliqi Bioscience Co Ltd. in your supply chain? Watch your suppliers from $19/mo →